Citurgia Biochemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve Unaudited Financial Results ....
Awaiting price reaction for this filing.
Citurgia Biochemicals Ltd has informed BSE that its Board of Directors will meet on Friday, 14th November 2025. The key agenda is to consider and approve the Unaudited Standalone Financial Results for the quarter and half year ended 30th September 2025 (Q2 FY26). The filing is made under Regulation 29 of the SEBI LODR Regulations, 2015, which governs prior intimation of board meetings that consider financial results. The trading window for insiders has been closed since 1st October 2025 and will reopen 48 hours after the results are announced. No financial figures or business details have been disclosed in this intimation — those will come after the board meeting.
This is a routine procedural filing with no immediate impact on shareholders. Investors should watch for the actual results announcement on or after 14th November 2025, which will reveal the company's Q2 FY26 performance. Until then, the stock remains in a closed trading window for insiders, signalling no material information has leaked ahead of the official release.